Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification…
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
LONDON, Oct. 20, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas…
Intas & Accord signs Agreement to acquire Prothya Biosolutions
AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary…
Intas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA
AHMEDABAD, India, Aug. 6, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its…
The Luanda Accord Marks Landmark Commitment to Support Natural Diamond Industry
~ Leading diamond producing countries announce their intention to allocate 1% of…
